Similar Search Results

Pharmaceutical regulation and health policy objectives

Birg, Laura - 2013

public expenditure, limiting financial exposure of patients, improving access to pharmaceuticals, and stimulating competition …

Persistent link: https://www.econbiz.de/10010224844

Pharmaceutical Regulation and Health Policy Objectives

Birg, Laura - 2014

public expenditure, limiting financial exposure of patients, improving access to pharmaceuticals, and stimulating competition …

Persistent link: https://www.econbiz.de/10014150467

Special FDA designations for drug development : orphan, fast track, accelerated approval, priority review, and breakthrough therapy

Michaeli, Daniel; Michaeli, Christoph T.; Albers, Sebastian - In: The European journal of health economics 25 (2024) 6, pp. 979-997

Persistent link: https://www.econbiz.de/10014633366

India's road to independence in manufacturing active pharmaceutical ingredients : focus on essential medicines

Cherian, Jerin Jose; Rahi, Manju; Singh, Shubhra; … - In: Economies : open access journal 9 (2021) 2, pp. 1-18

Background: Active Pharmaceutical Ingredient (API) manufacturing is an important segment of the Indian pharma industry. India ranks third in terms of volume of medicines produced, and is a major global supplier of generic medicines. However, India depends heavily on the import of several raw...

Persistent link: https://www.econbiz.de/10012547902